An international research team is perfecting a method to predict the potential clinical implications of new drugs before clinical trials even start. An international research team has develo... Read more
A research team at Dartmouth College has developed a new strategy for drug discovery and development that can be used to produce targeted therapies against diseases such as cancer and neurod... Read more
Most current medicines are derived from naturally occurring small molecules. Yet the lack of a systematic method for producing diverse nature-inspired small molecules has prevented the devel... Read more
A new technique for precisely targeting molecules within cells is paving the way for safer drugs that are free of side effects. Researcher J. Julius Zhu, PhD, of the School of Medicine, and... Read more
IonStar could upend industry standards, and quicken medical diagnosis and drug development A new protein analysis tool developed at the University at Buffalo could vastly increase the speed... Read more
Today, a new study published in Science by Professors Yossi Paltiel of the Hebrew University of Jerusalem and Ron Naaman from the Weizmann Institute of Science describes a breakthrough techn... Read more
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discov... Read more
Two drugs taken together can sometimes lead to outcomes that largely deviate from the effect of the separated compounds – a fact well known from warnings on patient information leaflet... Read more
Cocaine, nicotine, capsaicin. These are just three familiar examples of the hundreds of thousands of small molecules (also called specialized or secondary metabolites) that plants use as che... Read more
In the fall of 1999, a young chemical engineer named Todd Zion left his job at Eastman Kodak to enroll in the Ph.D. program at the Massachusetts Institute of Technology. While looking for a... Read more
There is clearly something wrong with pharmaceutical innovation. Antibiotic-resistant infections sicken more than two million Americans every year and kill at least 23,000. The World Health... Read more
Drug firms have new medicines and patients are desperate for them. But the arguments over cost are growing LOUIS MACHOGU, the owner of a pharmacy near Nairobi, has noticed a change. In the p... Read more
A new approach for moving promising discoveries out of laboratories and into the hands of patients and physicians With the “Valley of Death” looming as an increasingly serious obstacle to in... Read more
First, let’s get one thing straight. There is no “crisis.” Now that Novartis, GlaxoSmithKline, AstraZeneca, Merck, and Sanofi have either scaled back or (in the case of GSK... Read more
